Eczema Trial, Recruiting (NCT07568665)

Eczema Trial, Recruiting NCT07568665 Sponsor: Hôpitaux Drôme Nord Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT07568665 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have moderate-to-severe eczema (atopic dermatitis) that your doctor believes needs to be treated with a medicine called tralokinumab
You are covered by a social security or health insurance scheme
You are able to understand and agree to take part in the study on your own
You have been fully informed about the study and have signed a consent form together with the doctor running the trial

Who may not be able to join:

You do not wish to take part in the study, or you are legally unable to make your own decisions
You have an ongoing long-term health condition that is not well controlled and may need treatment with steroid medicines (corticosteroids)
You have another serious health condition that, in the doctor's opinion, could make it difficult or unsafe for you to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07568665

Sponsor: Hôpitaux Drôme Nord

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

More information: https://clinicaltrials.gov/study/NCT07568665

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have moderate-to-severe eczema (atopic dermatitis) that your doctor believes needs to be treated with a medicine called tralokinumab
You are covered by a social security or health insurance scheme
You are able to understand and agree to take part in the study on your own
You have been fully informed about the study and have signed a consent form together with the doctor running the trial

Who may not be able to join:

You do not wish to take part in the study, or you are legally unable to make your own decisions
You have an ongoing long-term health condition that is not well controlled and may need treatment with steroid medicines (corticosteroids)
You have another serious health condition that, in the doctor's opinion, could make it difficult or unsafe for you to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hôpitaux Drôme Nord

Registry

ClinicalTrials.gov

Start date

27 November 2025

Est. completion

1 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Thickness of the atopic skin

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov